Insulin-dependent patients with type 2 diabetes and obesity have significantly higher healthcare expenditures. A recent study stratifies these high-cost, high-need patients who might benefit most from interventions and medical weight loss management.
Type 2 diabetes (T2D) patients with co-morbid fatty liver disease who undergo gastric bypass surgery are more likely to experience long-term diabetes remission than are T2D patients without fatty liver, according to a large retrospective analysis by Cleveland Clinic researchers.
Patients can expect to lose additional weight on canagliflozin after weight loss plateau following metabolic surgery, according to a recently published randomized clinical trial. Endocrinologist Sangeeta Kashyap, MD, explains.
Supplementing with vitamin D3 has no significant clinical impact on diabetes prevention, according to a randomized clinical trial published in the New England Journal of Medicine.